BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35453551)

  • 1. Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis.
    Bauer A; Habior A; Gawel D
    Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-kelch-like 12 and anti-hexokinase 1 antibodies in primary biliary cholangitis patients in China.
    Liu ZY; Xu L; Liu B
    Rev Esp Enferm Dig; 2021 Aug; 113(8):585-590. PubMed ID: 33307711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.
    Norman GL; Yang CY; Ostendorff HP; Shums Z; Lim MJ; Wang J; Awad A; Hirschfield GM; Milkiewicz P; Bloch DB; Rothschild KJ; Bowlus CL; Adamopoulos IE; Leung PS; Janssen HJ; Cheung AC; Coltescu C; Gershwin ME
    Liver Int; 2015 Feb; 35(2):642-51. PubMed ID: 25243383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Reig A; Norman GL; Garcia M; Shums Z; Ruiz-Gaspà S; Bentow C; Mahler M; Romera MA; Vinas O; Pares A
    Am J Gastroenterol; 2020 Oct; 115(10):1634-1641. PubMed ID: 32467507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
    Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
    Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study.
    Norman GL; Reig A; Viñas O; Mahler M; Wunsch E; Milkiewicz P; Swain MG; Mason A; Stinton LM; Aparicio MB; Aldegunde MJ; Fritzler MJ; Parés A
    Front Immunol; 2019; 10():662. PubMed ID: 31001269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature.
    de Liso F; Matinato C; Ronchi M; Maiavacca R
    Clin Chem Lab Med; 2017 Nov; 56(1):25-31. PubMed ID: 28731850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to understand the clinical significance of autoantibodies in primary biliary cholangitis].
    Yan HP; Zhang HP; Chen XX
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):810-815. PubMed ID: 29325273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies.
    Wesierska-Gadek J; Klima A; Komina O; Ranftler C; Invernizzi P; Penner E
    Ann N Y Acad Sci; 2007 Aug; 1109():519-30. PubMed ID: 17785341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear envelope protein autoantigens in primary biliary cirrhosis.
    Worman HJ
    Hepatol Res; 2007 Oct; 37 Suppl 3():S406-11. PubMed ID: 17931195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Autoantibodies Against Nucleoporin p62 in Sera of Patients With Primary Biliary Cholangitis.
    Bauer A; Habior A
    Ann Lab Med; 2019 May; 39(3):291-298. PubMed ID: 30623621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
    Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis.
    Haldar D; Janmohamed A; Plant T; Davidson M; Norman H; Russell E; Serevina O; Chung K; Qamar K; Gunson B; Hansen B; Richter A; Trivedi PJ; Hirschfield GM
    Liver Int; 2021 Mar; 41(3):535-544. PubMed ID: 33022821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis.
    Bauer A; Rawa T
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
    Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
    Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis.
    Bauer A; Habior A
    J Clin Lab Anal; 2007; 21(4):227-31. PubMed ID: 17621358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis.
    Nickowitz RE; Wozniak RW; Schaffner F; Worman HJ
    Gastroenterology; 1994 Jan; 106(1):193-9. PubMed ID: 8276182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
    PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.